产品资料

人丝氨酸蛋白酶抑制剂|Human Vaspin

产品名称: 人丝氨酸蛋白酶抑制剂|Human Vaspin
产品型号: C02-130-11-100ug
产品展商: peprotech
产品文档: 无相关文档

简单介绍

人丝氨酸蛋白酶抑制剂|Human Vaspin系列产品主要适用于试验室或生化科研相关试验,CANSPEC品质提供的人丝氨酸蛋白酶抑制剂|Human Vaspin性能**,中文名称为人丝氨酸蛋白酶抑制剂|Human Vaspin。产品人丝氨酸蛋白酶抑制剂|Human Vaspin以其优良的品质满足您不同科研实验的多种需求。


人丝氨酸蛋白酶抑制剂|Human Vaspin  的详细介绍

产品名称:人丝氨酸蛋白酶抑制剂|Human Vaspin

产品规格:

C02-130-11-100ug人丝氨酸蛋白酶抑制剂|Human Vaspin100ug¥9,800
C02-130-11-1mg人丝氨酸蛋白酶抑制剂|Human Vaspin1mg¥42,000
C02-130-11-25ug人丝氨酸蛋白酶抑制剂|Human Vaspin25ug¥1,960
C02-130-11-500ug人丝氨酸蛋白酶抑制剂|Human Vaspin500ug¥25,200
C02-130-11-5ug人丝氨酸蛋白酶抑制剂|Human Vaspin5ug¥680

单        位:瓶

关 键 字:人丝氨酸蛋白酶抑制剂|Human Vaspin


CANSPEC品质提供的人丝氨酸蛋白酶抑制剂|Human Vaspin性能**,英文名称人丝氨酸蛋白酶抑制剂|Human Vaspin,简称为人丝氨酸蛋白酶抑制剂|Human Vaspin,中文名称为人丝氨酸蛋白酶抑制剂|Human Vaspin。

产品人丝氨酸蛋白酶抑制剂|Human Vaspin以其优良的品质满足您不同实验的多种需求。并保证每批人丝氨酸蛋白酶抑制剂|Human Vaspin的质量和人丝氨酸蛋白酶抑制剂|Human Vaspin品质优良。

Synonyms :

Visceral adipose tissue-derived serpin

Description :

Vaspin is a newly described adipocytokine expressed predominantly in visceral white adipose tissues. Structure analysis of Vaspin predicts the presence of three β-sheets, nine α-helices, and one central loop, which are distinctive structural features of Serpin family members. The serpins are irreversible (“suicidal”) serine-protease inhibitors, characterized by having more than 30% sequence homology with α1-antitrypsin and a conserved tertiary structure, which contains an exposed reactive center loop that acts as a pseudo-substrate for the target proteinase. Members of this family play an important role in a number of fundamental biological processes including blood coagulation, fibrinolysis, complement activation, angiogenesis, inflammation, and tumor suppression. In human, the serpins represent approximately 2% of total serum proteins, of which 70% is α1- antitrypsin. Vaspin exhibits 40.2% sequence identity with α-1-antitrypsin. Yet, its protease inhibitory activity is still unknown. Vaspin mRNA expression in visceral fat is positively correlated with BMI and percent of body fat. Administration of Vaspin to obese mice improved glucose tolerance and insulin sensitivity, reflected by normalized blood glucose levels. It also led to the reversal of altered expression of diabetes-relevant adipocytokines including leptin, adiponectin, resistin, and TNF-α. These findings suggest a potential clinical use for Vaspin in ameliorating certain aberrations seen in the diabetic/obesity metabolic syndrome. Recombinant human Vaspin is a 45.2 kDa protein containing 395 amino-acid residues.

Catalog #:

130-11

Source :

E.coli

Stability :

The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted Vaspin is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles.

Purity :

Greater than 98% by SDS-PAGE gel and HPLC analyses.

Endotoxin Level :

Endotoxin level is less than 0.1 ng per μg (1EU/μg).

Biological Activity :

Data Not Available.

AA Sequence :

MLKPSFSPRN YKALSEVQGW KQRMAAKELA RQNMDLGFKL LKKLAFYNPG RNIFLSPLSI STAFSMLCLG AQDSTLDEIK QGFNFRKMPE KDLHEGFHYI IHELTQKTQD LKLSIGNTLF IDQRLQPQRK FLEDAKNFYS AETILTNFQN LEMAQKQIND FISQKTHGKI NNLIENIDPG TVMLLANYIF FRARWKHEFD PNVTKEEDFF LEKNSSVKVP MMFRSGIYQV GYDDKLSCTI LEIPYQKNIT AIFILPDEGK LKHLEKGLQV DTFSRWKTLL SRRVVDVSVP RLHMTGTFDL KKTLSYIGVS KIFEEHGDLT KIAPHRSLKV GEAVHKAELK MDERGTEGAA GTGAQTLPME TPLVVKIDKP YLLLIYSEKI PSVLFLGKIV NPIGK

PubMed Link :

Vaspin

Country of Origin :

USA

沪公网安备 31011402005168号